Topiramate Capsule, Extended Release
Product Images NDC 70748-275

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70748-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cc039b2c 1602 4311 B976 9125434bc152 01)

Chemical structure diagram of Topiramate, showing its molecular arrangement with various oxygen, sulfur, and carbon atoms including sulfonamide and ketal functional groups.*

FDA Label Image

Image (Cc039b2c 1602 4311 B976 9125434bc152 02)

A line chart showing cumulative rates of time to first seizure over a period of 500 days comparing two dosage groups of Topiramate: 50 mg/day and 400 mg/day. The chart illustrates that the 50 mg/day group has a higher cumulative seizure rate than the 400 mg/day group, with a p-value of 0.0002 indicating statistical analysis.*

FDA Label Image

Image (Cc039b2c 1602 4311 B976 9125434bc152 03)

A bar chart showing the change from baseline to double-blind Phase 3b in average monthly migraine period rate (±SE) for placebo and topiramate at 50 mg/day, 100 mg/day, and 200 mg/day doses. Two studies (Study 1 and Study 2) are compared, with Study 1 bars in black and Study 2 bars in dark gray. Statistical significance indicators (* p<0.010, ** p<0.001) are noted below the chart.*

FDA Label Image

Topiramate Extended-release Capsules Usp, 25 mg30 Capsules Ndc 70748-275-06 (Cc039b2c 1602 4311 B976 9125434bc152 04)

Label for Topiramate Extended-Release Capsules USP 25 mg by Lupin Pharmaceuticals, Inc. The label indicates oral extended-release capsules, 25 mg strength, with a quantity of 30 capsules. It includes usage instructions, storage information, and manufacturing details for Lupin Pharmaceuticals, Inc. and Lupin Limited, India.*

FDA Label Image

Topiramate Extended-release Capsules, 50 mg30 Capsules Ndc 70748-276-06 (Cc039b2c 1602 4311 B976 9125434bc152 05)

Topiramate Extended-Release Capsules USP 50 mg label from Lupin Pharmaceuticals, Inc. The label includes dosage instructions, storage conditions, and a 30-capsule pack size. It specifies that each capsule contains 50 mg of topiramate USP and advises swallowing the capsule whole without crushing or chewing. The label also displays manufacturer and distributor information along with a QR code and barcode.*

FDA Label Image

Topiramate Extended-release Capsules, 100 mg30 Capsules Ndc 70748-277-06 (Cc039b2c 1602 4311 B976 9125434bc152 06)

Topiramate Extended-Release Capsules USP 100 mg, oral extended-release capsules in a bottle label by Lupin Pharmaceuticals, Inc. The label states dosing instructions, storage conditions, and manufacturer details, including Lupin Limited in India. The package contains 30 capsules. A QR code and barcode are also visible on the label.*

FDA Label Image

Topiramate Extended-release Capsules, 200 mg30 Capsules Ndc 70748-278-06 (Cc039b2c 1602 4311 B976 9125434bc152 07)

Label for Topiramate Extended-Release Capsules USP 200 mg by Lupin Pharmaceuticals, Inc. The label indicates 30 capsules per container, with instructions to swallow whole once daily. It includes storage instructions and a QR code linking to the medication guide. Manufactured by Lupin Limited in India.*

FDA Label Image

Image (Cc039b2c 1602 4311 B976 9125434bc152 294 1)

Topiramate extended-release capsules in a white and purple blister pack labeled with Lupin Pharmaceuticals, Inc. The package states 'Topiramate Extended Release Capsules USP 200 mg' and contains 60 capsules for oral use.*

FDA Label Image

Image (Cc039b2c 1602 4311 B976 9125434bc152 318 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.